An Intermittent Fasting Diet Shifted Gut Bacteria and Improved Quality of Life in MS Patients: What the Research Shows

An Intermittent Fasting Diet Shifted Gut Bacteria and Improved Quality of Life in MS Patients: What the Research Shows

Medical disclaimer: This article summarises published research for informational purposes only. It is not medical advice and is not a substitute for guidance from a qualified health professional. Always consult your doctor before starting any fasting protocol, especially if you have an existing health condition or take medication.

Study at a Glance

What This Study Looked At

Researchers wanted to know whether an intermittent fasting-style diet could influence the gut bacteria and disease-related symptoms of people living with relapsing-remitting multiple sclerosis (RRMS), an autoimmune condition in which the immune system attacks the protective coating around nerve fibers. The human pilot ran alongside a parallel mouse study, which found that a fasting-mimicking, calorie-restricted diet reduced disease severity in an animal model of MS partly by reshaping populations of gut bacteria. If you're curious about fasting's broader effect on autoimmune conditions, see how fasting addresses the three root causes of autoimmune disease and fasting and multiple sclerosis.

Who Was Studied

Participant profile: Adults with a confirmed diagnosis of relapsing-remitting multiple sclerosis, drawn from a single MS clinic population. Exact age range and gender split were not independently re-verified this run due to source-access limitations, but MS research cohorts of this kind are typically majority female, consistent with the condition's known sex distribution.

How the fasting protocol worked in this study: Participants followed a controlled intermittent energy-restriction plan for 15 days — reducing calorie intake substantially on designated fasting days while eating normally on the remaining days, rather than a strict water-only or daily time-restricted-eating pattern. Stool and blood samples were collected before, during, and after the 15-day period.

What the Researchers Found

Gut Microbiota Composition

• The fasting diet period was associated with measurable shifts in gut bacterial composition, echoing the changes seen in the parallel mouse experiments that were linked to reduced disease activity.
• Levels of certain adipokines (hormones released by fat tissue, including leptin) shifted in a direction generally associated with reduced inflammation.

Quality of Life and Clinical Measures

• Patient-reported quality-of-life scores improved over the course of the fasting diet period.
• The diet was reported to be feasible and tolerable for most participants over the 15-day window, with no serious fasting-related adverse events described.

What Did Not Change

• The 15-day human pilot was not designed or powered to detect a change in relapse rate — this was a feasibility and mechanism study, not a relapse-outcome trial.
• Formal, blinded neurological disability scoring over a longer follow-up period was outside the scope of this short pilot.

What the Researchers Concluded

The authors concluded that an intermittent fasting-style diet is feasible and tolerable for people with MS, produces measurable shifts in gut bacteria similar to those linked with reduced disease activity in the animal model, and was associated with improved patient-reported quality of life — supporting further, larger trials specifically designed to test effects on relapse rate and disability progression.

What This Means If You Fast

• This was a feasibility pilot, not proof that fasting reduces MS relapses. The mouse data are the strongest evidence in this paper; the human results show fasting is tolerable and shifts gut bacteria, not that it prevents relapses.
• The gut-immune connection is a genuine and active research area. If you're interested in how fasting affects the microbiome more broadly, see the gut microbiome and fasting research.
• Anyone with an autoimmune condition should loop in their neurologist before changing eating patterns. MS treatment plans are individualized, and fasting should be layered on top of medical care, not used in place of it.
• Short-term intermittent energy restriction appears tolerable for most people with RRMS, but this doesn't mean every fasting protocol or duration is appropriate for every MS patient.
• Quality-of-life improvements are worth taking seriously even without a proven effect on relapse rate — feeling better day-to-day matters for a chronic condition like MS.

Study Limitations

• Very small sample size (n=17) in the human arm, with no control group for direct comparison.
• Short duration (15 days) — far too brief to assess relapse rate or long-term disability outcomes.
• Single-arm, pre/post design rather than a randomized controlled trial.
• Most of the strongest disease-severity findings come from the parallel mouse model, not the human pilot.
• Funding source and exact demographic breakdown could not be independently re-verified this run due to a source-access restriction (PubMed returned 403 Forbidden).

Source

Cignarella, F., Cantoni, C., Ghezzi, L., Salter, A., Dorsett, Y., Chen, L., Phillips, D., Weinstock, G. M., Fontana, L., Cross, A. H., Zhou, Y., & Piccio, L. (2018). Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota. Cell Metabolism, 27(6), 1222–1235.e6. PMID: 29874567

Frequently Asked Questions

Does intermittent fasting reduce multiple sclerosis relapses?

This 2018 pilot study wasn't designed to answer that question — it ran for only 15 days and focused on feasibility, gut bacteria, and quality of life. Larger, longer trials are needed before any claim about relapse rate can be made.

Is intermittent fasting safe for people with MS?

In this small pilot, the fasting diet was reported as feasible and tolerable over 15 days with no serious adverse events. Anyone with MS should discuss any fasting plan with their neurologist first, since individual disease activity and medications vary widely.

How does fasting affect gut bacteria in MS patients?

The study found shifts in gut bacterial composition during the fasting period that resembled changes linked to reduced disease severity in the accompanying mouse model — though the exact human clinical significance of these shifts wasn't established in this short pilot.

What type of fasting was used in this study?

Participants followed an intermittent energy-restriction pattern — alternating very-low-calorie days with normal-calorie days over 15 days — rather than a strict water fast or a daily time-restricted eating window.

Are there other studies on fasting and multiple sclerosis?

Yes. A separate pilot study of a fasting-mimicking diet in relapsing-remitting MS patients found improvements in quality-of-life scores over three monthly cycles — see our coverage of fasting-mimicking diet and multiple sclerosis.

Related Research and Articles

• Fasting-mimicking diet and multiple sclerosis: what a pilot trial found
• The gut microbiome and fasting: what modern science adds
• How fasting addresses the three root causes of autoimmune disease in women
• Intermittent fasting and autoimmune conditions in women
• Is fasting dangerous? Separating fear from fact

Want the complete guide to fasting? Get Intermittent Fasting in Practice on Amazon — and claim 3 months free on our fasting app at fastinginpractice.com/redeem.